Mov Disord:帕金森患者,外周血的免疫特征如何?

2021-08-08 Freeman MedSci原创

与HCs相比,PD患者的外周免疫谱发生改变,NLR较高。

帕金森病(PD)是最常见的神经退行性疾病之一,但其发病机制仍不清楚。

目前的证据表明,神经炎症是帕金森病神经退行性疾病的病因和进展的一个主要因素。神经炎症不是对神经变性的简单反应,PD与中枢和外周的免疫反应都有关。

有证据表明,在PD中存在着脑-外周的相互作用,或者是通过胶质-淋巴途径,或者是通过血脑屏障的干扰。

据描述,与健康对照组(HCs)相比,PD患者的血液、脑脊液(CSF)和大脑中的促炎症细胞因子升高了。

在PD患者的外周血中,白细胞及其亚群的数量和质量都发生了变化。中性粒细胞与淋巴细胞比率(neutrophil-to-lymphocyte ratio,NLR)是一个公认的机体整体炎症状态的指标。

该比率整合了两种白细胞亚群和互补的免疫途径的信息:中性粒细胞与慢性炎症有关,而淋巴细胞可能代表调节途径。它已被用作癌症、血管和炎症性疾病的预后因素,以及阿尔茨海默病的认知障碍的标志物。有人认为NLR在PD中升高,作为外周炎症的生物标志物,但结果有争议。

藉此,西班牙Universitario Virgen del Rocío的Laura Muñoz-Delgado等人,探究了PD患者与HCs相比,是否存在促炎症的外周免疫状态。

他们首先通过病例对照研究探究了PD患者和HCs之间外周免疫状况的差异。

然后,探究了NLR是否与PD的临床特征有关。

最后,进行了荟萃分析以澄清NLR在PD中的作用。

他们发现:在病例对照研究中,PD患者的NLR明显高于HCs(2.47 ± 1.1 vs. 1.98 ± 0.91,P < 0.001)。

但没有发现NLR与发病年龄、疾病严重程度或疾病持续时间之间的关联。

荟萃分析显示,PD患者的NLR可能更高。

这个研究的重要意义在于发现了:与HCs相比,PD患者的外周免疫谱发生改变,NLR较高。


原文出处:
Peripheral Immune Profile and Neutrophil‐to‐Lymphocyte Ratio in Parkinson’s Disease. Mov Disord. Published online June 8, 2021:mds.28685. doi:10.1002/mds.28685

 
 
 
 

评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1784450, encodeId=ef211e84450c9, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Oct 16 20:07:51 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013682, encodeId=2d2b2013682fa, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Nov 08 20:07:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309253, encodeId=640f1309253c1, content=<a href='/topic/show?id=8dbb29086c6' target=_blank style='color:#2F92EE;'>#免疫特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29086, encryptionId=8dbb29086c6, topicName=免疫特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e080359, createdName=surilei, createdTime=Mon Aug 09 20:07:51 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578576, encodeId=113f15e85760d, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Mon Aug 09 20:07:51 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006100, encodeId=f5451006100cb, content=有收获, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05885564664, createdName=ms3000000120045871, createdTime=Sun Aug 08 19:06:08 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005989, encodeId=93111005989b1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201210/017ce76ad1014a7ab78fda1719777146/e1909743852a42449a457ef64bb5bfe8.jpg, createdBy=26641794232, createdName=ms812711744394816, createdTime=Sun Aug 08 10:55:25 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005951, encodeId=b9c2100595128, content=顶, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f685566957, createdName=jyq1990, createdTime=Sun Aug 08 08:42:41 CST 2021, time=2021-08-08, status=1, ipAttribution=)]
    2021-10-16 cmsvly
  2. [GetPortalCommentsPageByObjectIdResponse(id=1784450, encodeId=ef211e84450c9, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Oct 16 20:07:51 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013682, encodeId=2d2b2013682fa, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Nov 08 20:07:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309253, encodeId=640f1309253c1, content=<a href='/topic/show?id=8dbb29086c6' target=_blank style='color:#2F92EE;'>#免疫特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29086, encryptionId=8dbb29086c6, topicName=免疫特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e080359, createdName=surilei, createdTime=Mon Aug 09 20:07:51 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578576, encodeId=113f15e85760d, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Mon Aug 09 20:07:51 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006100, encodeId=f5451006100cb, content=有收获, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05885564664, createdName=ms3000000120045871, createdTime=Sun Aug 08 19:06:08 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005989, encodeId=93111005989b1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201210/017ce76ad1014a7ab78fda1719777146/e1909743852a42449a457ef64bb5bfe8.jpg, createdBy=26641794232, createdName=ms812711744394816, createdTime=Sun Aug 08 10:55:25 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005951, encodeId=b9c2100595128, content=顶, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f685566957, createdName=jyq1990, createdTime=Sun Aug 08 08:42:41 CST 2021, time=2021-08-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1784450, encodeId=ef211e84450c9, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Oct 16 20:07:51 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013682, encodeId=2d2b2013682fa, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Nov 08 20:07:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309253, encodeId=640f1309253c1, content=<a href='/topic/show?id=8dbb29086c6' target=_blank style='color:#2F92EE;'>#免疫特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29086, encryptionId=8dbb29086c6, topicName=免疫特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e080359, createdName=surilei, createdTime=Mon Aug 09 20:07:51 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578576, encodeId=113f15e85760d, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Mon Aug 09 20:07:51 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006100, encodeId=f5451006100cb, content=有收获, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05885564664, createdName=ms3000000120045871, createdTime=Sun Aug 08 19:06:08 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005989, encodeId=93111005989b1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201210/017ce76ad1014a7ab78fda1719777146/e1909743852a42449a457ef64bb5bfe8.jpg, createdBy=26641794232, createdName=ms812711744394816, createdTime=Sun Aug 08 10:55:25 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005951, encodeId=b9c2100595128, content=顶, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f685566957, createdName=jyq1990, createdTime=Sun Aug 08 08:42:41 CST 2021, time=2021-08-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1784450, encodeId=ef211e84450c9, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Oct 16 20:07:51 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013682, encodeId=2d2b2013682fa, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Nov 08 20:07:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309253, encodeId=640f1309253c1, content=<a href='/topic/show?id=8dbb29086c6' target=_blank style='color:#2F92EE;'>#免疫特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29086, encryptionId=8dbb29086c6, topicName=免疫特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e080359, createdName=surilei, createdTime=Mon Aug 09 20:07:51 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578576, encodeId=113f15e85760d, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Mon Aug 09 20:07:51 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006100, encodeId=f5451006100cb, content=有收获, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05885564664, createdName=ms3000000120045871, createdTime=Sun Aug 08 19:06:08 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005989, encodeId=93111005989b1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201210/017ce76ad1014a7ab78fda1719777146/e1909743852a42449a457ef64bb5bfe8.jpg, createdBy=26641794232, createdName=ms812711744394816, createdTime=Sun Aug 08 10:55:25 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005951, encodeId=b9c2100595128, content=顶, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f685566957, createdName=jyq1990, createdTime=Sun Aug 08 08:42:41 CST 2021, time=2021-08-08, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1784450, encodeId=ef211e84450c9, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Oct 16 20:07:51 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013682, encodeId=2d2b2013682fa, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Nov 08 20:07:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309253, encodeId=640f1309253c1, content=<a href='/topic/show?id=8dbb29086c6' target=_blank style='color:#2F92EE;'>#免疫特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29086, encryptionId=8dbb29086c6, topicName=免疫特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e080359, createdName=surilei, createdTime=Mon Aug 09 20:07:51 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578576, encodeId=113f15e85760d, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Mon Aug 09 20:07:51 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006100, encodeId=f5451006100cb, content=有收获, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05885564664, createdName=ms3000000120045871, createdTime=Sun Aug 08 19:06:08 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005989, encodeId=93111005989b1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201210/017ce76ad1014a7ab78fda1719777146/e1909743852a42449a457ef64bb5bfe8.jpg, createdBy=26641794232, createdName=ms812711744394816, createdTime=Sun Aug 08 10:55:25 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005951, encodeId=b9c2100595128, content=顶, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f685566957, createdName=jyq1990, createdTime=Sun Aug 08 08:42:41 CST 2021, time=2021-08-08, status=1, ipAttribution=)]
    2021-08-08 ms3000000120045871

    有收获

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1784450, encodeId=ef211e84450c9, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Oct 16 20:07:51 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013682, encodeId=2d2b2013682fa, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Nov 08 20:07:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309253, encodeId=640f1309253c1, content=<a href='/topic/show?id=8dbb29086c6' target=_blank style='color:#2F92EE;'>#免疫特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29086, encryptionId=8dbb29086c6, topicName=免疫特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e080359, createdName=surilei, createdTime=Mon Aug 09 20:07:51 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578576, encodeId=113f15e85760d, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Mon Aug 09 20:07:51 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006100, encodeId=f5451006100cb, content=有收获, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05885564664, createdName=ms3000000120045871, createdTime=Sun Aug 08 19:06:08 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005989, encodeId=93111005989b1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201210/017ce76ad1014a7ab78fda1719777146/e1909743852a42449a457ef64bb5bfe8.jpg, createdBy=26641794232, createdName=ms812711744394816, createdTime=Sun Aug 08 10:55:25 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005951, encodeId=b9c2100595128, content=顶, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f685566957, createdName=jyq1990, createdTime=Sun Aug 08 08:42:41 CST 2021, time=2021-08-08, status=1, ipAttribution=)]
    2021-08-08 ms812711744394816

    学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1784450, encodeId=ef211e84450c9, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Oct 16 20:07:51 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013682, encodeId=2d2b2013682fa, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Mon Nov 08 20:07:51 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309253, encodeId=640f1309253c1, content=<a href='/topic/show?id=8dbb29086c6' target=_blank style='color:#2F92EE;'>#免疫特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29086, encryptionId=8dbb29086c6, topicName=免疫特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e080359, createdName=surilei, createdTime=Mon Aug 09 20:07:51 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1578576, encodeId=113f15e85760d, content=<a href='/topic/show?id=fd724282021' target=_blank style='color:#2F92EE;'>#外周血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42820, encryptionId=fd724282021, topicName=外周血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31916414168, createdName=ms3994565386320060, createdTime=Mon Aug 09 20:07:51 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006100, encodeId=f5451006100cb, content=有收获, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05885564664, createdName=ms3000000120045871, createdTime=Sun Aug 08 19:06:08 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005989, encodeId=93111005989b1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201210/017ce76ad1014a7ab78fda1719777146/e1909743852a42449a457ef64bb5bfe8.jpg, createdBy=26641794232, createdName=ms812711744394816, createdTime=Sun Aug 08 10:55:25 CST 2021, time=2021-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005951, encodeId=b9c2100595128, content=顶, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f685566957, createdName=jyq1990, createdTime=Sun Aug 08 08:42:41 CST 2021, time=2021-08-08, status=1, ipAttribution=)]
    2021-08-08 jyq1990

    0

相关资讯

Mov Disord:认知行为疗法,有助于减轻帕金森患者的焦虑状态?

认知行为疗法,有助于减轻帕金森患者的焦虑状态?

Mov Disord:神经黑色素变化,和帕金森病的恶化高度相关

神经黑色素变化,和帕金森病的恶化高度相关

Mov Disord-新型标记物: 鞘氨醇-1-磷酸酯可预测帕金森的病情进展

新型标记物: 鞘氨醇-1-磷酸酯可预测帕金森的病情进展

Mov Disord:血液中的细胞外囊泡,可有效诊断帕金森

德国波恩大学研究团队发现血浆胞外囊泡中的α-synuclein浓度,可作为PD的潜在诊断生物标志物。

Mov Disord:双侧卵巢切除术后,女性更容易患帕金森病

双侧卵巢切除术后,女性更容易患帕金森病。

Mov Disord:早期帕金森患者,脑脊液的神经递质如何变化?

早期帕金森患者,脑脊液的神经递质如何变化?

拓展阅读

好文推荐 | 八段锦对轻中度帕金森病患者情绪及睡眠质量的影响

本研究探讨八段锦对PD患者的情绪和睡眠质量的改善及其机制。

Nat Aging:大规模蛋白质组学分析揭示帕金森病的新病理机制和潜在生物标志物

这项研究通过大规模蛋白质组学分析,揭示了帕金森病的新病理机制,并发现了多个潜在的生物标志物。

帕金森病无症状期诊断新突破:基于tRFs的血液检测方法

当前难以满足帕金森病早期诊断的需求,该研究提出了一种基于血液检测的无症状诊断新方法,通过定量分析转移RNA片段(tRFs)中重复序列基序,实现了对帕金森病的早期、精准且低成本的检测。

Brain:帕金森病中神经黑色素耗竭与皮质节律活动之间的关联

注意力相关的 α 波段活动与去甲肾上腺素能系统的功能障碍有关,与运动障碍相关的 β 活动反映了多巴胺能功能障碍。

帕金森病:中西医健康需求的质性研究

研究呼吁政策制定者、医疗机构与科研团队协同合作,推动中西医结合从“经验医学”向“精准医学”转型,为全球PD管理提供中国方案。

【协和医学杂志】帕金森病患者脑深部电刺激术后神经精神功能障碍发生率及其影响因素分析:一项前瞻性队列研究

本研究拟通过前瞻性队列研究进一步明确DBS治疗患者PND发生率,并分析其影响因素,以期为更准确地识别PND并制订有效的管理策略提供更高级别的数据支持。

帕金森病经颅超声检查中国指南

中国医师协会超声医师分会 · 2025-02-20

2025 BAN共识指南:帕金森病的管理-第II部分:非运动症状

巴西神经病学学会(BAN,Brazilian Academy of Neurology) · 2025-01-31

中国经颅超声检查帕金森病规范与诊断指南

中国医师协会超声医师分会 · 2025-02-14